Study Stopped
Technical difficulties with ambulatory equipment led to unacceptably high levels of data loss. As we would have had to suspend data collection under Covid precautions in any case, we decided to terminate in March of this year.
The Effects of Lateralized Thermal Sleepwear on Sleep, Skin Temperature and Skin Moisture in Menopausal Women
The Effects of Sleepwear With Lateralized Thermal Characteristics on Sleep, Proximal Skin Temperature and Sternal Skin Moisture in Menopausal Women
1 other identifier
interventional
4
1 country
1
Brief Summary
A home-based, sham-controlled, double-blind, crossover study evaluating the effects of wearing sleepwear with lateralized thermal characteristics on subjective and objective sleep measures, proximal skin temperature, and sternal skin moisture in menopausal women complaining of sleep disturbance and vasomotor symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 19, 2017
CompletedFirst Posted
Study publicly available on registry
January 31, 2017
CompletedStudy Start
First participant enrolled
May 21, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2020
CompletedApril 1, 2021
March 1, 2021
2.8 years
January 19, 2017
March 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Total Sleep Time
Minutes of sleep of any stage, as scored by conventional criteria, across recording period.
Two nights in the experimental condition and two nights in the control condition.
Wakefulness After Sleep Onset
Minutes of Wakefulness, as scored by conventional criteria, from first epoch of sleep until end of recording period.
Two nights in the experimental condition and two nights in the control condition.
Minutes of non-rapid eye movement (NREM) Stage 1 Sleep
Minutes of NREM Stage 1 Sleep, as scored by conventional criteria, across recording period.
Two nights in the experimental condition and two nights in the control condition.
Secondary Outcomes (1)
Proximal Skin Temperature
Measurements taken every 90 seconds across two-night experimental and control conditions
Other Outcomes (2)
Position Monitoring
Position sampled every two seconds across two nights in experimental condition and two nights in control condition
Sternal Skin Moisture
Measurements taken every three minutes across two nights in experimental condition and two nights in control condition
Study Arms (2)
Lateralized Thermal Sleepwear
EXPERIMENTALFor two consecutive nights subjects will wear Sleepwear with Lateralized Thermal Characteristics
Sham-Lateralized Sleepwear
SHAM COMPARATORFor two consecutive nights subjects will wear Sham-Lateralized Sleepwear
Interventions
Subjects will wear sleepwear constructed with insulating fabric on one side and conductive fabric on the other side, arranged bilaterally.
Subjects will wear sleepwear constructed with two insulating fabrics arranged bilaterally.
Eligibility Criteria
You may qualify if:
- At least 12 months since last menstrual period
- Subjective complaint of sleep disturbance, confirmed by Pittsburgh Sleep Quality Index score greater than 5
- Subjective complaint of at least moderate symptoms of menopause, confirmed by modified Kupperman score greater than 15
- Ability to sleep in the left lateral, right lateral and supine positions
You may not qualify if:
- Unable to taper off, with health care provider's agreement, hypnotic or sedative medications, hormone replacement therapy, clonidine, gabapentin, or isoflavones and other botanical compounds used to treat vasomotor symptoms of menopause
- Unable to taper to two or fewer caffeinated beverages per day
- Unable to taper to one or fewer alcoholic beverages per day
- Unable to taper off nicotine in any form
- Unable to taper off recreational drugs
- Subjective sleep, based on two-week sleep logs, averaging less than 4.0 or greater than 7.5 hours per night
- Clinical suspicion of obstructive sleep apnea, periodic leg movements or other significant physiological sleep disturbance
- Known skin allergy to silver, cotton, nylon, surgical tape and other adhesives
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Peter's Sleep Center
Albany, New York, 12205, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul Glovinsky, Ph.D.
St. Peter's Sleep Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Masking Details
- Treatment and sham-control sleepwear will be allocated to subjects in a counterbalanced manner by a study administrator who will not otherwise interact with subjects.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Director, St. Peter's Sleep Center
Study Record Dates
First Submitted
January 19, 2017
First Posted
January 31, 2017
Study Start
May 21, 2017
Primary Completion
March 15, 2020
Study Completion
March 15, 2020
Last Updated
April 1, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share